Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-22
2005-03-22
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S240000, C548S247000
Reexamination Certificate
active
06869969
ABSTRACT:
Isoxazole estrogen receptor agonist and antagonist compounds having unexpected and surprising activity in modulating estrogen receptor activity are described. In addition, methods and compositions for treating or preventing estrogen receptor-mediated disorders are disclosed. The compounds, methods, and compositions of the invention have utility in preventing or treating estrogen receptor-mediated disorders such as osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer's disease.
REFERENCES:
patent: 4112108 (1978-09-01), Nadelson
patent: 4229204 (1980-10-01), Howe
patent: 4268678 (1981-05-01), Diana et al.
patent: 5512564 (1996-04-01), Zilch et al.
patent: 5547967 (1996-08-01), Kehrbach et al.
patent: 5565482 (1996-10-01), Talley et al.
patent: 5859257 (1999-01-01), Talley
patent: 5861359 (1999-01-01), Theodoridis
patent: 6030970 (2000-02-01), Elliot et al.
patent: 6069141 (2000-05-01), Barbachyn et al.
patent: 6114328 (2000-09-01), Wityak et al.
patent: 6114367 (2000-09-01), Cohan et al.
patent: 6187797 (2001-02-01), Pruitt et al.
patent: 6221876 (2001-04-01), Gruber et al.
patent: 6245796 (2001-06-01), Maceno et al.
patent: 6441014 (2002-08-01), Talley et al.
patent: 6495582 (2002-12-01), Hale et al.
patent: 6531498 (2003-03-01), Eggenweiler et al.
patent: 6579880 (2003-06-01), Weidner-Wells et al.
patent: 6583141 (2003-06-01), Freyne et al.
patent: 6613719 (2003-09-01), Kudis et al.
patent: 6624311 (2003-09-01), DiCosimo et al.
patent: DD 295 360 (1983-10-01), None
patent: DD 295 630 (1983-10-01), None
patent: 2 250 343 (1972-10-01), None
patent: 24 41504 (1975-03-01), None
patent: 31 19727 (1982-12-01), None
patent: 38 32 570 (1988-09-01), None
patent: 41 26543 (1993-02-01), None
patent: 4230839 (1993-03-01), None
patent: 0 761 654 (1977-03-01), None
patent: 026928 (1981-04-01), None
patent: 0 405 905 (1991-01-01), None
patent: 0 435 381 (1991-07-01), None
patent: 442448 (1991-08-01), None
patent: 0 456 519 (1991-11-01), None
patent: 0 577 218 (1994-01-01), None
patent: 623603 (1994-11-01), None
patent: 2104932 (1972-04-01), None
patent: 55-83766 (1980-06-01), None
patent: 3-74374 (1991-03-01), None
patent: 3-208044 (1991-09-01), None
patent: 7-215952 (1995-08-01), None
patent: WO 9415920 (1994-07-01), None
patent: WO 9417059 (1994-08-01), None
patent: WO 9418201 (1994-08-01), None
patent: WO 9504049 (1995-02-01), None
patent: WO 9506032 (1995-03-01), None
patent: WO 9513262 (1995-05-01), None
patent: 9625405 (1996-08-01), None
patent: 9701551 (1997-01-01), None
patent: WO 9705115 (1997-02-01), None
patent: WO 9711690 (1997-04-01), None
Shankar et al., “One Pot Solid Phase Synthesis of Isoxazolines”, Tetrahedron Letters, 39 (1998) 2447-2448.
Taylor et al., “Simultaneous On-Line Characterization of Small Organic Modecules Derived from Combinatorial Libraries for Identify, Quantity, and Purity by Reversed-Phase HPLC with Chemiluminescent Nitrogen, UV, and Mass Spectrometric Detection”, AC Research, Anal. Chem., 1998, 70, 3339-3347.
Doyle et al., “Derivatives of 6-Aminopenicillanic Acid. Part VII. Further 3,5-Disubstituted Isoxazole-4-Carboxylic Acid Derivatives”, Journal of The Chemical Society, Dec. 1963, pp. 5845-5854.
Hanson et al., “Derivatives of 6-Aminopenicillanic Acid. Part VIII, Further Analogues of 3-o-Chlorophenyl-5-methyl-4-isoxazolypenicillin”, Journal of the Chemical Society, Nov. 1965, pp. 5976-5983.
Doyle et al., “Derivatives of 6-Aminopenicillanic Acid. Part VI, Penicillins from 3-and 5-Phenylisoxazole-4-carboxylic Acids and their Alkyl and Halogen Derivatives”, Journal of The Chemical Society, Dec. 1963, pp. 5838-5845.
Hamper et al., “Synthesis and Herbicidal Activity of 3-Aryl-5-(haloalkyl)-4isoxazolecarboxamides and Their Derivatives”, J. Agric. Food Chem. 1995, 43, pp. 219-228.
Shanker et al., Synthesis and Cleavage Reactions of Benzothiazepinyl Chromone Derivatives, Phosphoros, Sulfur, and Silicon, 1989, vol. 44, pp. 143-147.
Amme et al., “Synthesis, Binding Affinities and Uterotrophic Activity of Some 2-Substituted Estradiol and Ring-A-Fused Pyrone Derivatives”Eur. J. Med. Chem. 29:25-32, 1994.
Duncan et al., “The Preparation of N-Carboalkoxypyrazoles and N-Phenylpyrazoles from C(α)-Dianions of Carboalkoxyhydrazones and Phenylhydrazones”J. Heterocyclic Chem. 24:555, 1987.
Fink et al., “Novel Structural Templates for Estrogen-Receptor Ligands and Prospects for Combinatorial Synthesis of Estrogens”Chemistry and Biology 6:205-219, Apr., 1999.
Sun et al., “Novel Ligands that Function as Selective Estrogens or Antiestrogens for Estrogen Receptor-α or Estrogen Receptor-β”Endrocrinology 140(2):800-804, 1999.
Wachter et al., “Tetrahydronaphthalenes: Influence of Heterocyclic Substituents on Inhibition of Steroidogenic Enzymes P450 arom and P450 17”J. Med. Chem. 39:834-841, 1996.
Meisenheimer et al., “Uber Triaryl-Isoxazole”Chemische Berichte3195-3206, 1921.
Krishna et al., “Synthesis and Physiological Activity of 3-Hydrxy-Pheny-5-Aryl Isoxazoles”Chemical Abstracts 79(13):487, 1973.
Yamawaki et al., “Synthesis and Biological Activity of the Metabolites of [3, 4-Bis(4-Methoxyphenyl)-5-Isoxazolyl] Acetic Acid”Chemical and Pharmaceutical Bulletin 36(8):3142-3146, 1988.
Kim et al., “Reactions of 5-Substituted 3-Alkyl- and 3-Aryl-Isoxaozoles with Tetrasulfur Tetranitride Antimony Pentachloride Complex (S4N4SbCl5): Complete Regioselective Formation of 4-Substituted 3-Acyl- and 3-Aroyl-1, 2,5-Thiadiozoles and Their Mechanism of Formation”J. Chemical Society 14:2175-2180, 1998.
Mohan et al., “Search for Physiologically Active Compounds XIV Synthesis of Some 3,5-Disubstituted Isoxazoles and Their Physiological Activity”Chemical Abstracts 69(11):4107, 1968.
Wrobel et al., “Conversion of 1-(O-Nitroaryl) Alkyl P-Tolysulfones into Isoxazoles”Heterocycles 40(1):187-190, 1995.
Kasturi et al., “Reaction of Spironaphthalenones with Hydroxylamine Hydrochloride: Part IV”Tetrahedron 51(10):3051-3060, 1995.
Bass, R.G., Polymer Preprints (American Chemical Society) 32(2):160-161, 1991.
Sulfonyl pyrazoles and isoxazoles: cycloaddition of nitrile imines and nitrile oxides to aryl styryl sulfones. Padmavathi, et al., Department of Chemistry, Sri Venkateswara University, Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1998), 37B(12), 1286-1289. (abstract).
Reactions of 5-substituted 3-alkyl- and 3-aryl-isoxazoles with tetrasulfur tetranitride antimony pentachloride complex (S4N4.SbCI5): complete regioselective formation of 4-substituted 3-acyl- and 3-aroyl-1,2,5-thiadiazoles and their mechanism of formation. [Erratum to document cited in CA129:175594]. Kim, et al., Department of Chemistry, Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1998), (18). 3121. (abstract).
Intermolecular cycloaddition of nitrile imines and nitrile oxides to 1,3-diarylprop-2-en-1 -ones. Padmavathi, et al., Department of Chemistry, Heterocyclic Communications (1998), 4(2), 163-168. (abstract).
Reactions of 5-substituted 3-alkyl- and 3-arylisoxazoles with tetrasulfur tetranitride antimony pentachloride complex (S4N4.SbCI5): complete regioselective formation of 4-substituted 3-acyl- and 3-aroyl-1,2,5-thiadiazoles and their mechanism of formation. Kim, et al., Department of Chemistry, Seoul National University, Seoul, S. Korea. Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1998), (14), 2175-2180. (abstract).
Some reactions of I-phenyl-3-(4,6-dimethoxy- or 4,6,7-trimethoxy-5-benzofuranyl)-1,3-propanedione. Saleh, Nadia M. Faculty of Science, Chemistry Department, AI-Azhar University, (for girls), Nasr City, Egypt. Al-Azhar Bulletin of Science (1996), 7(1, Pt. 1), 19-27. (abstract).
1,3-diphenylpropane-1, 3-diamines. Part VIII. Reactions of lithiated oximes and oxime ethers with C:N-electrophiles. Kaise
Chen Liya
Desai Manoj
Huebner Verena D.
James Ian
Krywult Beata
Austin James E.
Chiron Corporation
Collier Steven W.
Harbin Alisa A.
Lambkin Deborah C.
LandOfFree
Estrogen receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogen receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3406005